本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pyxis Oncology, Inc.

1.20
-0.0400-3.23%
盘后1.250.0500+4.17%19:52 EDT
成交量:32.40万
成交额:39.47万
市值:7,433.72万
市盈率:-0.77
高:1.25
开:1.25
低:1.20
收:1.24
数据加载中...
2023/05/10

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/28

重要事件披露

8-K - Current report
2023/03/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/22

重要事件披露

8-K - Current report
2023/03/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/16

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/01

重要事件披露

8-K - Current report
2022/11/10

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/01

重要事件披露

8-K - Current report
2022/11/01

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/07

重要事件披露

8-K - Current report